Cycurion, Inc. 8-K
Research Summary
AI-generated summary
Cycurion Inc. Approves Warrant Issuance Potentially Diluting Shares
What Happened Cycurion, Inc. (CYCU) filed an 8-K on March 20, 2026 reporting the results of a special meeting of stockholders. As of the January 21, 2026 record date, the Company had 5,148,411 shares of Voting Stock outstanding (4,188,187 common; 960,224 preferred on an as-converted basis) and 2,611,518 shares were represented at the meeting. Stockholders approved, pursuant to Nasdaq Listing Rule 5635(d), the Warrant Exercise Proposal to permit issuance of up to 3,314,920 shares of Common Stock upon exercise of certain warrants issued in a private placement that closed December 5, 2025. The Company also approved an Adjournment Proposal (to allow adjournment if further solicitation of proxies were needed). The Company furnished a press release dated March 17, 2026 as Exhibit 99.1 to the 8-K.
Key Details
- Total voting stock outstanding (record date Jan 21, 2026): 5,148,411 shares (4,188,187 common; 960,224 preferred on as-converted basis).
- Shares represented at the special meeting: 2,611,518.
- Warrant Exercise Proposal vote: For 2,359,348; Against 164,438; Abstain 5,773; Non‑votes 81,959.
- Adjournment Proposal vote: For 2,460,423; Against 143,588; Abstain 7,207; Non‑votes 0.
- The warrants at issue were issued in connection with a private placement that closed December 5, 2025; exercise could result in up to 3,314,920 new common shares.
Why It Matters The shareholder approval clears the way for the exercise of private‑placement warrants that could add up to 3,314,920 common shares—potentially a material increase in share count and dilution for existing common shareholders. Approval was required under Nasdaq rules because the issuance could equal or exceed 20% of the common stock outstanding immediately prior to the offering. Investors should note the potential dilution and monitor any future warrant exercises or related filings for timing and financial impact.
Loading document...